PTON vs TARS · P/E 92, rev $2.49B vs rev $183.0M
Peloton Interactive Inc (PTON) versus Tarsus Pharmaceuticals Inc (TARS) — a side-by-side from cached financials, not a winner call.
Peloton Interactive Inc (PTON) is a leisure company listed on NASDAQ.
Tarsus Pharmaceuticals Inc (TARS) is a biotechnology company listed on NASDAQ.
Latest reported PTON revenue for 2025-06-30 was $2.49B. Net income was -$118.9M. Revenue was down 7.8% from 2024-06-30 to 2025-06-30. PTON currently screens at market cap $2.39B and trailing P/E 92.2.
Latest reported TARS revenue for 2024-12-31 was $183.0M. Net income was -$115.6M. Revenue was up 948.6% from 2023-12-31 to 2024-12-31. TARS currently screens at market cap $2.66B.
PTON currently screens at market cap $2.39B and trailing P/E 92.2. TARS currently screens at market cap $2.66B.
Not investment advice. Open the PTON and TARS stock pages for the full models.
Not investment advice.